Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Avi Kapoor 1 month ago
MarketsTrading IdeasPre-Market OutlookEquities
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
- Wall Street expects Abivax SA (NASDAQ:ABVX) to post a first-half loss of $1.08 per share on revenue of $1.86 million after the closing bell, according to data from Benzinga Pro. Abivax shares fell 0.5% to $104.50 in the after-hours trading session.
- Marygold Companies Inc. (NYSE:MGLD) posted a loss of 8 cents per share for the fourth quarter, versus a year-ago loss of 4 cents per share. The company’s sales fell to $6.925 million from $7.200 million. Marygold Companies shares dipped 15.1% to $0.90 in the after-hours trading session.
- Neuphoria Therapeutics Inc. (NASDAQ:NEUP) posted a loss of 95 cents per share for the fourth quarter, missing market estimates of a loss of 56 cents per share. The company’s sales came in at $1.174 million for the quarter. Neuphoria Therapeutics shares fell 0.4% to close at $3.70 on Friday.
Check out our premarket coverage here
- Accenture Plc (NYSE:ACN) announced a partnership to establish a team of embedded evaluators at Anthropic. Accenture shares jumped 8.1% to $195.88 in after-hours trading.
- Lobo Technologies Ltd. (NASDAQ:LOBO) reported a year-over-year increase in H1 financial results. Lobo Technologies shares jumped 26.7% to $0.67 in the after-hours trading session.
Photo via Shutterstock